Russia's Sputnik V developers call on AstraZeneca to try combining vaccines

Developers of the Sputnik V Covid-19 vaccine said on Thursday that AstraZeneca should try combining its experimental shot with the Russian one to boost efficacy.
 

Russia said its Sputnik V vaccine is 92% effective at protecting people from Covid-19, according to interim trial results, while AstraZeneca said its Covid-19 vaccine was 70% effective in pivotal trials and could be up to 90% effective.
 

"If they go for a new clinical trial, we suggest trying a regimen of combining the AZ shot with the #SputnikV human adenoviral vector shot to boost efficacy," the developers of the Russian vaccine said on their